Although the BECN1 gene is not considered a highly mutated gene in cancer (0.5% of all cancers), its monoallelic deletion can be seen in approximately 40% to 75% of ovarian, prostate, and breast cancers, which is why it is described as a “haploinsufficient tumor suppressor” gene.44, 77. Here, BECN1 is linked to neoplasm.